1. tn44777
2. 7dorehardtop
3. byf5
1.tn44777 05/14/2018
Denali Therapeutics Reports First Quarter 2018 Financial Results
2.byf5 05/30/2018
DNLI exercised option to acquire all outstanding shares in F-star Gamma
3.7dorehardtop 03/19/2018
Denali Therapeutics Announces First-In-Human Dosing Of Its RIPK1 Inhibitor Clinical Program And The Appointment Of Peter Klein To Board Of Directors; Reports Fourth Quarter And Full Year 2017 Financia
4.7dorehardtop 05/11/2018
Reports Q1 EPS loss of $0.26
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW